DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

AbbVie Inc. (NYSE: ABBV)

55.60 -0.10 (-0.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABBV $55.60 -0.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.52
Previous Close $55.70
Daily Range $55.25 - $55.68
52-Week Range $42.26 - $58.27
Market Cap $88.5B
P/E Ratio 21.59
Dividend (Yield) $1.68 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 7,277,853
Average Daily Volume 12,993,121
Current FY EPS $3.16



AbbVie Inc. (ABBV) Description

AbbVie Inc. Website:

News & Commentary

Why Repros Therapeutics Inc. Stock Rocketed Higher

Repros Therapeutics' stock is among today's top gainers after the company's lead experimental drug goes head-to-head against a rival and easily comes out on top.

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog

S&P 500 And Aristocrat Dividend Dogs Tag 4.2% To 20.2% August Upsides

AbbVie: Growth Story Or Patent Expiration Nightmare?

I Am Sure This Pharma-Company Suits Your Portfolio

After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

Is It Time to Buy AbbVie Stock?

A multi-billion dollar acquisition is in the works with huge potential tax savings. Is now the right time to buy AbbVie stock?

John Paulson's Big Q2 Buys

3 Reasons Celgene Corporation's Stock Could Fall

Celgene shares are up more than 1,200% over the past decade. But these three headwinds could be the brick wall that sends its stock lower.

Kinder Morgan Inadvertently Names A 'Dividend Growth Starter Kit'

See More ABBV News...